secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001104659-23-099306
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics raises ~$550k in private placement at $0.717/share from Fortress and Rosenwald
--------------------------------------------------------------------------------

- Issued 767,085 shares at $0.717/share (Nasdaq closing bid on Sept 7, 2023) to Fortress Biotech and Dr. Lindsay Rosenwald.
- No underwriting or placement agent fees incurred; gross proceeds ~$550,000.
- Proceeds intended for working capital and general corporate purposes.
- Registration rights agreement obligates filing of resale registration statement by September 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923099306/0001104659-23-099306-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923099306/tm2325730d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-099306

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer